Enzo Biochem Inc. ENZ is an integrated life sciences and biotechnology firm that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on ENZ's earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Enzo Biochem could be a solid choice for investors.
Current Quarter Estimates for ENZ
In the past 30 days, 1 estimate moved up for Enzo Biochem but there was no downward revision. The consensus estimate trend has been pretty favourable, with estimates narrowing from a loss of 32 cents to loss of 24 cents, a significant move.
Current Year Estimates for ENZ
Meanwhile, Enzo Biochem's current year figures are also looking quite promising, with 1 estimate moving higher in the past month, compared to no downward revisions. The consensus estimate trend has also seen a boost for this time frame, estimate narrowing from a loss of 8 cents to a loss of 7 cents in the past one month time frame.
Bottom Line
The stock has also started to move higher lately, adding 36.4% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #2 Enzo Biochem stock to profit in the near future.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on ENZ's earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Enzo Biochem could be a solid choice for investors.
Current Quarter Estimates for ENZ
In the past 30 days, 1 estimate moved up for Enzo Biochem but there was no downward revision. The consensus estimate trend has been pretty favourable, with estimates narrowing from a loss of 32 cents to loss of 24 cents, a significant move.
Current Year Estimates for ENZ
Meanwhile, Enzo Biochem's current year figures are also looking quite promising, with 1 estimate moving higher in the past month, compared to no downward revisions. The consensus estimate trend has also seen a boost for this time frame, estimate narrowing from a loss of 8 cents to a loss of 7 cents in the past one month time frame.
Bottom Line
The stock has also started to move higher lately, adding 36.4% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #2 Enzo Biochem stock to profit in the near future.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ENZO BIOCHEM ENZ: Get Free Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
